We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Same-Day PET-Guided Biopsies Rush Preoperative Work-Up for Breast Cancer Patients and Reduce Radiation Exposure

By HospiMedica International staff writers
Posted on 16 May 2011
Clinicians have demonstrated how positron emission mammography (PEM)-guided biopsy may expedite preoperative work-up and reduce radiation exposure for breast cancer patients. More...


Researchers from the University of Cincinnati (OH, USA) presented their findings from a prospective study at the American Roentgen Ray Society 2011 annual meeting on May 3, 2011, held in Chicago (IL, USA).

PEM scanners are high-resolution breast positron emission tomography (PET) systems that can show the location as well as the metabolic phase of a lesion. This information is crucial in determining whether a lesion is malignant and influences the course of treatment. Naviscan's (San Diego, CA, USA) Stereo Navigator accessory is the first commercialized PET-guided biopsy tool, and has been cleared by the US Food and Drug Administration (FDA) since 2008.

"PEM is useful for performing local staging in women with newly diagnosed breast cancer," stated Dr. Amy Argus, assistant professor of radiology and one of the lead investigators of the study. "When additional breast abnormalities are identified by PEM, accurate PEM-guided biopsy can be performed on the same day as the diagnostic imaging, which decreases the patient's radiation dose and may expedite their preoperative work-up."

In this study, 18 women with breast cancer classified as BIRADS [Breast Imaging-Reporting and Data System]-5 identified on mammography or ultrasound, underwent a PEM scan and same day PEM-guided biopsy on 24 index and satellite lesions. Lesion size was 4 mm - 60 mm with a mean size of 16 mm. Results were concordant for 83% of lesions and discordant for the remaining due to patient movement and operator experience.

PEM is the only technology where physicians are able to biopsy on the same injection of the radiotracer. This is because the radiotracer utilized, fluorodeoxyglucose (FDG), does not washout of the tumor as with other blood flow-dependant modalities like magnetic resonance imaging (MRI) or breast-specific gamma imaging (BSGI). By avoiding a double injection of radiotracer, the radiation exposure to the patient and medical personnel is reduced. Same-day procedures are also feasible with PEM given the ease of interpretation compared to other advanced imaging modalities.

Related Links:
University of Cincinnati
Naviscan



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.